Smokers: Clinical Trials

5 trials for Smokers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 withdrawn. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Withdrawn 1
Phase 11Completed 1

Follow Smokers: new trials by email Literature Review of Smokers trials Research Report on Smokers

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nicotine Patch Safety Study
V0116 transdermal patch, Nicotine transdermal patch - Smokers
Phase 2CompletedPierre Fabre Medicament1602012-08-012012-12-11
Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking.
NIC002, Placebo - Smokers
Phase 2CompletedNovartis2002008-08-012017-03-21
D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)
D-cycloserine, Placebo - Smokers
Phase 2WithdrawnBoston University Charles River Campus2008-08-012017-05-01
4 mg Nicotine Polacrilex Gum and Swedish Portion Snus
Nicotine - Healthy Subjects, Smokers
Phase 1 / Phase 2CompletedContract Research Organization el AB152006-03-012010-08-16
Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers
CYT002-NicQb - Smokers
Phase 2CompletedCytos Biotechnology AG3412003-12-012010-11-15

Narrower conditions

Smoking Cessation (2)  ·  Smoking (1)  ·  Tobacco Use Disorder (1)

Broader conditions

Behavior (3)  ·  Health Behavior (2)  ·  Chemically-Induced Disorders (1)  ·  Mental Disorders (1)  ·  Substance-Related Disorders (1)

Interventions

Chewing Gum (1)  ·  Cycloserine (1)  ·  Nicotine (1)  ·  Nicotine Chewing Gum (1)  ·  Tobacco Use Cessation Devices (1)  ·  nicotine Qbeta vaccine (1)

Sponsors

Boston University Charles River Campus (1)  ·  Contract Research Organization el AB (1)  ·  Cytos Biotechnology AG (1)  ·  Novartis (1)  ·  Pierre Fabre Medicament (1)

Countries

France (1)  ·  Germany (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Erik Lunell, MD, PhD (1)  ·  Felix Jungi, MD (1)  ·  Jacques Cornuz, Prof. (1)  ·  Karl Klingler, MD (1)  ·  Thomas Cerny, Prof. (1)

Results publications

PMID 18575629